- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04301388
Management of Threatened Preterm Labor by Cervical Length-based Approach or Conventional Approach
August 5, 2021 updated by: Kuntharee Traisrisilp, ChaingMai University
A Comparison of the Effectiveness in Management of Threatened Preterm Labor Between Cervical Length-based Approach and Conventional Approach: A Randomized Control Trial
To compare the effectiveness of treatment of threatened preterm labor between transvaginal cervical length-based approach and conventional approach (Per vaginal examination)
Study Overview
Status
Withdrawn
Intervention / Treatment
Study Type
Interventional
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Chiang Mai, Thailand, 50200
- Kuntharee Traisrisilp
-
ChiangMai, Thailand, 50200
- Maharaj Nakorn Chiangmai Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
Female
Description
Inclusion Criteria:
- Pregnant with symptoms of threatened preterm labor which refer to regular uterine contractions at least 1 time in every 10 minutes and persist for 30 minute without cervical dilatation or cervical dilation ≤ 1 cm and < 80% of effacement.
- Age ≥ 18 years
- Singleton pregnancy
- 24 0/7 - 33 6/7 weeks of gestation
- Uneventful antenatal care or low-risk pregnancies
Exclusion Criteria:
- The definitive diagnosis of true labor
- Proceed to the active phase of labor
- Age < 18 years
- Multiple pregnancies
- < 24 or ≥ 34 weeks of gestation
- Fetal chromosomal or structural abnormalities
- Abnormal fetal growth
- Abnormal amniotic fluid
- Evidence of placenta previa
- Significant vaginal bleeding that cannot be ruled out placenta previa
- Evidence of rupture of membranes
- Evidence of intrauterine infection
- Evidence of uterine malformation
- Evidence of lethal fetal malformation
- Unable to communicate or understand the information of the study
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: PREVENTION
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
EXPERIMENTAL: TVCL-based
Monitor progression of labor by shortening of cervix examined by transvaginal cervical length
|
Transvaginal ultrasound to measure cervical length if persist regular uterine contraction
|
ACTIVE_COMPARATOR: Conventional-based
Monitor progression of labor by per vaginal exam to detect cervical change
|
Transvaginal ultrasound to measure cervical length if persist regular uterine contraction
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Number of cases with delivery within 7 day after admission
Time Frame: From admission to no uterine contraction in 10 minute
|
In case of threatened preterm labor if detection the progression of labor by transvaginal cervical length, the rate of delivery within 7 days will less or more than conventional group.
|
From admission to no uterine contraction in 10 minute
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
The number of tocolysis courses, length of hospital stay
Time Frame: From admission to no uterine contraction in 10 minute
|
In case of tocolytic used for stop labor.
The number of medication will be recorded.
|
From admission to no uterine contraction in 10 minute
|
The number of steroid courses
Time Frame: From admission to no uterine contraction in 10 minute
|
In case of stop labor, the course of steroid for promote lung maturity is recorded.
|
From admission to no uterine contraction in 10 minute
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
January 22, 2020
Primary Completion (ACTUAL)
May 4, 2020
Study Completion (ANTICIPATED)
January 1, 2021
Study Registration Dates
First Submitted
March 6, 2020
First Submitted That Met QC Criteria
March 6, 2020
First Posted (ACTUAL)
March 10, 2020
Study Record Updates
Last Update Posted (ACTUAL)
August 9, 2021
Last Update Submitted That Met QC Criteria
August 5, 2021
Last Verified
August 1, 2021
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- OBG-2562-06699
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Transvaginal ultrasound
-
University Hospital MuensterCompleted
-
Washington University School of MedicineNational Cancer Institute (NCI)Completed
-
University of AarhusCompleted
-
Aljazeera HospitalKasr El Aini HospitalUnknown
-
ART Fertility Clinics LLCCompletedEndometrial DiseasesUnited Arab Emirates
-
Intermountain Women and Children's ResearchUnknownCervical InsufficiencyUnited States
-
Semmelweis UniversityCharles University, Czech Republic; Jagiellonian University; St John of God Hospital...Not yet recruitingEndometriosis | Radiculopathy | Nerve Sheath TumorHungary
-
Dina Mohamed Refaat DakhlyCompleted
-
Hadassah Medical OrganizationUnknownIn Vitro FertilizationIsrael
-
Cairo UniversityCompletedTrans Abdominal Ultrasound | Transvaginal Ultrasound | Lower Uterine Segment ThicknessEgypt